The influence of gender and sex steroids on craniofacial nociception

Headache

Volumn 47, Issue 2, 2007, Pages 319-324

  Cairns, Brian E ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Afferent fiber; Craniofacial; Estrogen; Pain; Receptors; Sex related difference; Temporomandibular disorder; Trigeminal

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; ESTROGEN; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SEX HORMONE;

CLUSTER HEADACHE; CRANIOFACIAL PAIN; EXPERIMENTAL ANIMAL; EXPERIMENTAL MODEL; FACE PAIN; GONADECTOMY; HUMAN; JAW DISEASE; MENSTRUAL CYCLE; MIGRAINE; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROESTRUS; REVIEW; SEX DIFFERENCE; TENSION HEADACHE; THERMAL STIMULATION;

ESTROGENS; FACIAL PAIN; FEMALE; GONADAL STEROID HORMONES; HUMANS; MALE; NEURONS, AFFERENT; NOCICEPTORS; SEX CHARACTERISTICS; TRIGEMINAL NERVE;

EID: 33846978772     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2006.00708.x     Document Type: Review

References (80)

1. LeResche L. Epidemiology of temporomandibular disorders: Implications for the investigation of etiologic factors. Crit Rev Oral Biol Med. 1997;8:291-305.
2. LeResche L. Epidemiology of orofacial pain. In: Lund JP, Lavigne GJ, Dubner R, Sessle BJ, eds. Orofacial Pain: From Basic Science to Clinical Management. Chicago: Quintessence; 2001:15-26.
3. Lavigne G, Woda A, Truelove E, Ship JA, Dao T, Goulet JP. Mechanisms associated with unusual orofacial pain. J Orofac Pain. 2005;19:9-21.
4. Savage NW, Boras VV, Barker K. Burning mouth syndrome: Clinical presentation, diagnosis and treatment. Australas J Dermatol. 2006;47:77-81.
5. Holroyd KA, Lipchik GL. Sex differences in recurrent headache disorders: Overview and significance. In: Fillingim RB, ed. Sex, Gender and Pain. Seattle: IASP Press; 2000:251-279.
6. Taylor JW, Cleary JD. Primary headache disorder. In: DiPiro JT, Talbert RL, Hayes PE, Yee GC, Posey LM, eds. Pharmacotherapy: A Pathophysiologic Approach. New York: Elsevier; 1989:660-670.
7. Fillingim RB, Maixner W, Kincaid S, Sigurdsson A, Harris MB. Pain sensitivity in patients with temporomandibular disorders: Relationship to clinical and psychosocial factors. Clin J Pain. 1996;12:260-269.
8. Fillingim RB. Sex, gender, and pain: Women and men really are different. Curr Rev Pain. 2000;4:24-30.
9. Fillingim RB, Maixner W. Sex-related factors in temporomandibular disorders. In: Fillingim RB, ed. Sex, Gender and Pain. Seattle: IASP Press; 2000:309-325.
10. Moskowitz MA. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology. 1993;43:S16-S20.
11. Moskowitz MA. Basic mechanisms in vascular headache. Neurol Clin. 1990;8:801-815.
12. Strassman AM, Raymond SA, Burstein R. Sensitization of meningeal sensory neurons and the origin of headaches. Nature. 1996;384:560-564.
13. Connors MJ. Cluster headache: A review. J Am Osteopath Assoc. 1995;95:533-539.
14. Levy D, Strassman AM. Distinct sensitizing effects of the cAMP-PKA second messenger cascade on rat dural mechanonociceptors. J Physiol. 2002;538:483-493.
15. Strassman AM, Raymond SA. Electrophysiological evidence for tetrodotoxin-resistant sodium channels in slowly conducting dural sensory fibers. J Neurophysiol. 1999;81:413-424.
16. Dostrovsky JO, Davis KD, Kawakita K. Central mechanisms of vascular headaches. Can J Physiol Pharmacol. 1991;69:652-658.
17. Bove GM, Moskowitz MA. Primary afferent neurons innervating guinea pig dura. J Neurophysiol. 1997;77:299-308.
18. Levy D, Strassman A. Mechanical response properties of A and C primary afferent neurons innervating the rat intracranial dura. J Neurophysiol. 2002;88:3021-3031.
19. Ambalavanar R, Moritani M, Haines A, Hilton T, Dessem D. Chemical phenotypes of muscle and cutaneous afferent neurons in the rat trigeminal ganglion. J Comp Neurol. 2003;460:167-179.
20. O'Connor TP, van der Kooy D. Enrichment of a vasoactive neuropeptide (calcitonin gene related peptide) in the trigeminal sensory projection to the intracranial arteries. J Neurosci. 1988;8:2468-2476.
21. Goadsby PJ. Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches. Drugs. 2005;65:2557-2567.
22. Juhasz G, Zsombok T, Modos EA, et al. NO-induced migraine attack: Strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain. 2003;106:461-470.
23. Levy D, Burstein R, Strassman AM. Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: Implications for the pathophysiology of migraine. Ann Neurol. 2005;58:698-705.
24. Strassman AM, Levy D. Response properties of dural nociceptors in relation to headache. J Neurophysiol. 2006;95:1298-1306.
25. Cairns BE, Sessle BJ, Hu JW. Characteristics of glutamate-evoked temporomandibular joint afferent activity in the rat. J Neurophysiol. 2001;85:2446-2454.
26. Cairns BE, Hu JW, Arendt-Nielsen L, Sessle BJ, Svensson P. Sex-related differences in human pain perception and rat afferent discharge evoked by injection of glutamate into the masseter muscle. J Neurophysiol. 2001;86:782-791.
27. Cairns BE, Dong XD, Svensson P, Arendt-Nielsen L, Sessle BJ. Sex-related differences in NMDA-evoked masseter muscle nociceptor discharge. In: Abstracts of the 11th World Congress on Pain. Seattle: IASP Press; 2005:566.
28. Cairns BE, Svensson P, Wang K, et al. Activation of peripheral NMDA receptors contributes to human pain and rat afferent discharges evoked by injection of glutamate into the masseter muscle. J Neurophysiol. 2003;90:2098-2105.
29. Cairns BE, Sessle BJ, Hu JW. Evidence that excitatory amino acid receptors within the temporomandibular joint region are involved in the reflex activation of the jaw muscles. J Neurosci. 1998;18:8056-8064.
30. Bolay H, Moskowitz MA. The emerging importance of cortical spreading depression in migraine headache. Rev Neurol (Paris). 2005;161:655-657.
31. Schaumburg HH, Byck R, Gerstl R, Mashman JH. Monosodium L-glutamate: Its pharmacology and role in the Chinese restaurant syndrome. Science. 1969;163:826-828.
32. Cananzi AR, D'Andrea G, Perini F, Zamberlan F, Welch KM. Platelet and plasma levels of glutamate and glutamine in migraine with and without aura. Cephalalgia. 1995;15:132-135.
33. Ferrari MD, Odink J, Bos KD, Malessy MJ, Bruyn GW. Neuroexcitatory plasma amino acids are elevated in migraine. Neurology. 1990;40:1582-1586.
34. Bartsch T, Goadsby PJ. Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input. Brain. 2002;125:1496-1509.
35. Burstein R, Yamamura H, Malick A, Strassman AM. Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol. 1998;79:964-982.
36. Cumberbatch MJ, Williamson DJ, Mason GS, Hill RG, Hargreaves RJ. Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5-HT1B/1D agonist. Br J Pharmacol. 1999;126:1478-1486.
37. Davis KD, Dostrovsky JO. Activation of trigeminal brain-stem nociceptive neurons by dural artery stimulation. Pain. 1986;25:395-401.
38. Davis KD, Dostrovsky JO. Responses of feline trigeminal spinal tract nucleus neurons to stimulation of the middle meningeal artery and sagittal sinus. J Neurophysiol. 1988;59:648-666.
39. Ellrich J, Andersen OK, Messlinger K, Arendt-Nielsen L. Convergence of meningeal and facial afferents onto trigeminal brainstem neurons: An electrophysiological study in rat and man. Pain. 1999;82:229-237.
40. Schepelmann K, Ebersberger A, Pawlak M, Oppmann M, Messlinger K. Response properties of trigeminal brain stem neurons with input from dura mater encephali in the rat. Neuroscience. 1999;90:543-554.
41. Strassman A, Mason P, Moskowitz M, Maciewicz R. Response of brainstem trigeminal neurons to electrical stimulation of the dura. Brain Res. 1986;379:242-250.
42. Lambert GA, Donaldson C, Boers PM, Zagami AS. Activation of trigeminovascular neurons by glyceryl trinitrate. Brain Res. 2000;887:203-210.
43. Messlinger K, Ellrich J. Meningeal nociception: Electrophysiological studies related to headache and referred pain. Microsc Res Tech. 2001;53:129-137.
44. Bereiter DA. Sex differences in brainstem neural activation after injury to the TMJ region. Cells Tissues Organs. 2001;169:226-237.
45. Okamoto K, Tashiro A, Hirata H, Bereiter DA. Differential modulation of TMJ neurons in superficial laminae of trigeminal subnucleus caudalis/upper cervical cord junction region of male and cycling female rats by morphine. Pain. 2005;114:203-211.
46. Okamoto K, Hirata H, Takeshita S, Bereiter DA. Response properties of TMJ neurons in superficial laminae at the spinomedullary junction of female rats vary over the estrous cycle. J Neurophysiol. 2003;89:1467-1477.
47. Takeshita S, Hirata H, Bereiter DA. Intensity coding by TMJ-responsive neurons in superficial laminae of caudal medullary dorsal horn of the rat. J Neurophysiol. 2001;86:2393-2404.
48. Bereiter DA, Barker DJ. Hormone-induced enlargement of receptive fields in trigeminal mechanoreceptive neurons. I. Time course, hormone, sex and modality specificity. Brain Res. 1980;184:395-410.
49. Mogil JS, Chesler EJ, Wilson SG, Juraska JM, Sternberg WF. Sex differences in thermal nociception and morphine antinociception in rodents depend on genotype. Neurosci Biobehav Rev. 2000;24:375-389.
50. Craft RM. Sex differences in opioid analgesia: From mouse to man. Clin J Pain. 2003;19:175-186.
51. Cai BB, Cairns BE, Sessle BJ, Hu JW. Sex-related suppression of reflex jaw muscle activity by peripheral morphine but not GABA. Neuroreport. 2001;12:3457-3460.
52. Clemente JT, Parada CA, Veiga MC, Gear RW, Tambeli CH. Sexual dimorphism in the antinociception mediated by kappa opioid receptors in the rat temporomandibular joint. Neurosci Lett. 2004;372:250-255.
53. Gear RW, Miaskowski C, Gordon NC, Paul SM, Heller PH, Levine JD. The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain. Pain. 1999;83:339-345.
54. Brandes JL. The influence of estrogen on migraine: A systematic review. JAMA. 2006;295:1824-1830.
55. Butcher RL, Collins WE, Fugo NW. Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17beta throughout the 4-day estrous cycle of the rat. Endocrinology. 1974;94:1704-1708.
56. Puri V, Puri S, Svojanovsky SR, et al. Effects of oestrogen on trigeminal ganglia in culture: Implications for hormonal effects on migraine. Cephalalgia. 2006;26:33-42.
57. Amandusson A, Hermanson O, Blomqvist A. Estrogen receptor-like immunoreactivity in the medullary and spinal dorsal horn of the female rat. Neurosci Lett. 1995;196:25-28.
58. Bereiter DA, Cioffi JL, Bereiter DF. Oestrogen receptor-immunoreactive neurons in the trigeminal sensory system of male and cycling female rats. Arch Oral Biol. 2005;50:971-979.
59. Flores CA, Shughrue P, Petersen SL, Mokha SS. Sex-related differences in the distribution of opioid receptor-like 1 receptor mRNA and colocalization with estrogen receptor mRNA in neurons of the spinal trigeminal nucleus caudalis in the rat. Neuroscience. 2003;118:769-778.
60. Flake NM, Bonebreak DB, Gold MS. Estrogen and inflammation increase the excitability of rat temporomandibular joint afferent neurons. J Neurophysiol. 2005;93:1585-1597.
61. Cairns BE, Sim Y, Bereiter DA, Sessle BJ, Hu JW. Influence of sex on reflex jaw muscle activity evoked from the rat temporomandibular joint. Brain Res. 2002;957:338-344.
62. Seo K, Fujiwara N, Cairns BE, Someya G. Male rats require testosterone to develop contralateral digastric muscle activity in response to noxious stimulation of the temporomandibular joint. Neurosci Lett. 2002;335:107-110.
63. Martin V, Behbehani M. Fos expression of trigeminal nucleus caudalis neurons after dural activation during different states of the rat estrous cycle. Headache. 2005;45:788.
64. Cairns BE. Influence of estrus cycle stage on response properties of rat masseter muscle afferent fibres. J Pain. 2004;5S:35.
65. Mann MK, Dong XD, Svensson P, Cairns BE. Influence of intramuscular nerve growth factor injection on the response properties of rat masseter muscle afferent fibers. J Orofac Pain. 2006;20:325-326.
66. Puri V, Cui L, Liverman CS, et al. Ovarian steroids regulate neuropeptides in the trigeminal ganglion. Neuropeptides. 2005;39:409-417.
67. Pardutz A, Multon S, Malgrange B, Parducz A, Vecsei L, Schoenen J. Effect of systemic nitroglycerin on CGRP and 5-HT afferents to rat caudal spinal trigeminal nucleus and its modulation by estrogen. Eur J Neurosci. 2002;15:1803-1809.
68. MacGregor EA. Oestrogen and attacks of migraine with and without aura. Lancet Neurol. 2004;3:354-361.
69. Welch KM, Brandes JL, Berman NE. Mismatch in how oestrogen modulates molecular and neuronal function may explain menstrual migraine. Neurol Sci. 2006;27:S190-S192.
70. Martin VT, Behbehani M. Ovarian hormones and migraine headache: Understanding mechanisms and pathogenesis - part 2. Headache. 2006;46:365-386.
71. Martin VT, Behbehani M. Ovarian hormones and migraine headache: Understanding mechanisms and pathogenesis - part I. Headache. 2006;46:3-23.
72. Gazerani P, Andersen OK, Arendt-Nielsen L. A human experimental capsaicin model for trigeminal sensitization. Gender-specific differences. Pain. 2005;118:155-163.
73. Gazerani P, Wang K, Cairns BE, Svensson P, Arendt-Nielsen L. Subcutaneous glutamate-evoked pain, sensitization and vasomotor responses in human skin. Pain. 2006;124:338-348.
74. Svensson P, Cairns BE, Wang K, et al. Glutamate-evoked pain and mechanical allodynia in the human masseter muscle. Pain. 2003;101:221-227.
75. Ernberg M, Lundeberg T, Kopp S. Effect of propranolol and granisetron on experimentally induced pain and allodynia/hyperalgesia by intramuscular injection of serotonin into the human masseter muscle. Pain. 2000;84:339-346.
76. Sherman JJ, LeResche L, Mancl LA, Huggins K, Sage JC, Dworkin SF. Cyclic effects on experimental pain response in women with temporomandibular disorders. J Orofac Pain. 2005;19:133-143.
77. Isselee H, De Laat A, DeMot B, Lysens R. Pressure-pain threshold variation in temporomandibular disorder myalgia over the course of the menstrual cycle. J Orofac Pain. 2002;16:105-117.
78. LeResche L, Mancl L, Sherman JJ, Gandara B, Dworkin SF. Changes in temporomandibular pain and other symptoms across the menstrual cycle. Pain. 2003;106:253-261.
79. Martin VT, Behbehani MM. Toward a rational understanding of migraine trigger factors. Med Clin North Am. 2001;85:911-941.
80. LeResche L, Saunders K, Von Korff MR, Barlow W, Dworkin SF. Use of exogenous hormones and risk of temporomandibular disorder pain. Pain. 1997;69:153-160.